{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:45:20Z","timestamp":1772196320939,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":4993,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.micinf.2010.02.001","type":"journal-article","created":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T06:54:27Z","timestamp":1265871267000},"page":"382-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccine"],"prefix":"10.1016","volume":"12","author":[{"given":"Nima Hosseini","family":"Jazani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Karimzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebrahim","family":"Mazloomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Sohrabpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhair Muhammad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojjat","family":"Ghasemnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Roshan-Milani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Shahabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2010.02.001_bib1","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1365-2222.2006.02606.x","article-title":"Regulation of the T cell response","volume":"36","author":"Romagnani","year":"2006","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.micinf.2010.02.001_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0923-2494(92)80057-R","article-title":"Freund's complete adjuvant: an effective but disagreeable formula","volume":"143","author":"Claassen","year":"1992","journal-title":"Res. Immunol."},{"key":"10.1016\/j.micinf.2010.02.001_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/hv.4.5.6438","article-title":"Vaccine adjuvants: the dream becomes real","volume":"4","author":"Tagliabue","year":"2008","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.micinf.2010.02.001_bib4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2008.04.036","article-title":"Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens","volume":"364","author":"Perrie","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micinf.2010.02.001_bib5","author":"Lewcock"},{"key":"10.1016\/j.micinf.2010.02.001_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/vim.2007.0101","article-title":"Effective induction of type 1 helper IgG2a and cytotoxic T-cell responses in mice following immunization with human papillomavirus type 16 E2 in MF59","volume":"21","author":"Heinemann","year":"2008","journal-title":"Viral Immunol."},{"key":"10.1016\/j.micinf.2010.02.001_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/cimm.1996.0252","article-title":"Reversal of age-related deficient influenza virus-specific CTL responses and IFN-gamma production by monophosphoryl lipid A","volume":"173","author":"Mbawuike","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1016\/j.micinf.2010.02.001_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4615-1823-5_9","article-title":"Structure and properties of aluminum-containing adjuvants","volume":"6","author":"Hem","year":"1995","journal-title":"Pharm. Biotechnol."},{"key":"10.1016\/j.micinf.2010.02.001_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","article-title":"Opioids, opioid receptors, and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.micinf.2010.02.001_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2005.02.002","article-title":"Multiple opioid receptors on immune cells modulate intracellular signaling","volume":"20","author":"Sharp","year":"2006","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.micinf.2010.02.001_bib11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(25)11336-0","article-title":"Chronic morphine administration impairs cell-mediated immune responses in swine","volume":"260","author":"Molitor","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.micinf.2010.02.001_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0162-3109(94)00052-H","article-title":"Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice","volume":"29","author":"Carpenter","year":"1995","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.micinf.2010.02.001_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","article-title":"Microbial infections, immunomodulation, and drugs of abuse","volume":"16","author":"Friedman","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micinf.2010.02.001_bib14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1749-6632.2000.tb05440.x","article-title":"The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in normal and skin-grafted mice","volume":"917","author":"Sacerdote","year":"2000","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.micinf.2010.02.001_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2249.1998.00680.x","article-title":"Endogenous opioids modulate allograft rejection time in mice: possible relation with Th1\/Th2 cytokines","volume":"113","author":"Sacerdote","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.micinf.2010.02.001_bib16","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V95.6.2031","article-title":"The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in BALB\/cJ mice","volume":"95","author":"Sacerdote","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.micinf.2010.02.001_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0955-3959(01)00080-9","article-title":"Legal aspects of providing naloxone to heroin users in the United States","volume":"12","author":"Burris","year":"2001","journal-title":"Int J Drug Pol"},{"key":"10.1016\/j.micinf.2010.02.001_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.micpath.2007.06.001","article-title":"Naloxone, an opioid receptor antagonist, enhances induction of protective immunity against HSV-1 infection in BALB\/c mice","volume":"43","author":"Jamali","year":"2007","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micinf.2010.02.001_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/intimm\/dxn139","article-title":"A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine","volume":"21","author":"Jamali","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.micinf.2010.02.001_bib21","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.4049\/jimmunol.161.8.4146","article-title":"Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses","volume":"161","author":"Yeung","year":"1998","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.micinf.2010.02.001_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.micinf.2010.02.001_bib23","series-title":"Immunology","article-title":"Short protocols in immunology: a compendium of methods from current protocols","author":"Coligan","year":"2005"},{"key":"10.1016\/j.micinf.2010.02.001_bib24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0196-9781(94)90028-0","article-title":"Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects","volume":"15","author":"Barcellini","year":"1994","journal-title":"Peptides"},{"key":"10.1016\/j.micinf.2010.02.001_bib25","series-title":"Pharmacotherapeutics for Advanced Practice: A Practical Approach","year":"2005"},{"key":"10.1016\/j.micinf.2010.02.001_bib26","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI200316750","article-title":"Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation","volume":"111","author":"Philippe","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.micinf.2010.02.001_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0143-4179(90)90140-T","article-title":"Modulation of a peripheral inflammatory response to substance P by locally administered opioid receptor agonists","volume":"17","author":"Khalil","year":"1990","journal-title":"Neuropeptides"},{"key":"10.1016\/j.micinf.2010.02.001_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nri1810","article-title":"Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens","volume":"6","author":"Sternberg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2010.02.001_bib29","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/gut.2006.105122","article-title":"Micro-Opioid receptor activation prevents acute hepatic inflammation and cell death","volume":"56","author":"Chakass","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.micinf.2010.02.001_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0165-2478(02)00128-1","article-title":"Expression of functional kappa-opioid receptors on murine dendritic cells","volume":"84","author":"Kirst","year":"2002","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micinf.2010.02.001_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1749-6632.2003.tb03144.x","article-title":"Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages","volume":"992","author":"Sacerdote","year":"2003","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.micinf.2010.02.001_bib32","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.4049\/jimmunol.178.11.7006","article-title":"In vivo signaling through the neurokinin 1 receptor favors transgene expression by langerhans cells and promotes the generation of Th1- and Tc1-biased immune responses","volume":"178","author":"Mathers","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.micinf.2010.02.001_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000097239","article-title":"Substance P primes murine peritoneal macrophages for an augmented proinflammatory cytokine response to lipopolysaccharide","volume":"3","author":"Berman","year":"1996","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.micinf.2010.02.001_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.bjp.0703782","article-title":"Contralateral but not systemic administration of the kappa-opioid agonist U-50,488H induces anti-nociception in acute hindpaw inflammation in rats","volume":"132","author":"Bileviciute-Ljungar","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.micinf.2010.02.001_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2004.09.003","article-title":"Neurokinin-1 receptor interacts with PrP(106-126)-induced dendritic cell migration and maturation","volume":"158","author":"Kaneider","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.micinf.2010.02.001_bib36","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nri1461","article-title":"Immune responses to Listeria monocytogenes","volume":"4","author":"Pamer","year":"2004","journal-title":"Nat. Rev. Immunol."}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645791000033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645791000033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:25:05Z","timestamp":1761143105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S128645791000033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S128645791000033X"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2010.02.001","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccine","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2010.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}